Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients

scientific article published on January 1981

Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.19.1.147
P932PMC publication ID181374
P698PubMed publication ID7247354

P2093author name stringJ J Schentag
F B Cerra
M A French
M E Plaut
P2860cites workControlled Comparison of Amikacin and GentamicinQ28324094
Gentamicin blood levels: a guide to nephrotoxicityQ34934750
Accumulation pharmacokinetics of tobramycinQ36468777
Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosidesQ36484544
Letter: Prolonged excretion of gentamicin in a patient with umimpaired renal functionQ39315405
Early detection of aminoglycoside nephrotoxicity with urinary beta-2-microglobulinQ39528831
Concentrations of gentamicin and amikacin in human kidneysQ40946641
Tissue Persistence of Gentamicin in ManQ41273225
Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycinQ44097867
Comparative tissue accumulation of gentamicin and tobramycin in patientsQ44900238
Comparative pharmacokinetics of amikacin and kanamycin.Q52906650
Gentamicin disposition and tissue accumulation on multiple dosingQ67053863
Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal functionQ71135148
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectamikacinQ408529
gentamicinQ422482
pharmacokineticsQ323936
P304page(s)147-152
P577publication date1981-01-01
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleAmikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients
P478volume19